Ask most people what worries them about artificial intelligence in healthcare and you will hear the same answer. It is not that the machine might be wrong. It is that nobody can explain why it decided what it decided.
That worry is fair. For a decade, the most powerful AI systems have been the least transparent ones. They read millions of records, spot patterns no human could see, and produce an answer. What they rarely produce is a reason. In most industries, that trade-off is tolerable. If a streaming service recommends a film you hate, you lose two hours. In medicine, the stakes are different. A machine that quietly labels a patient with a disease they do not have can change their insurance, their treatment, and their records for years.
The interesting news is that a quieter branch of AI is winning ground precisely because it refuses to be mysterious.
Two kinds of machine thinking
Modern AI splits roughly into two camps. Neural networks learn by example. Show them ten million medical notes and they get eerily good at guessing what the next note says. Symbolic systems work the other way. They start with rules written by people, such as the actual criteria a doctor uses to diagnose diabetes, and apply them step by step.
Neural networks are fast and flexible but struggle to explain themselves. Symbolic systems explain everything but are rigid. For years the two camps barely spoke.
The hybrid approach, called neuro-symbolic AI, joins them. The neural half reads messy human language in clinical notes. The symbolic half checks what it finds against explicit medical rules and keeps a record of every step. The result is a system that can say: this patient’s record supports this diagnosis, here is the sentence in the doctor’s note, here is the clinical rule it satisfies, and here is the trail an auditor can follow.
Why this matters beyond the lab
In the United States, this technology has found a serious job. Health insurers that run Medicare Advantage plans, the private version of America’s public insurance for older adults, are paid according to how sick their members are. Sicker patients mean higher payments, which is fair when the diagnoses are real and a scandal when they are not.
American regulators have spent the last two years auditing those diagnoses aggressively. Federal reviews published in March 2026 found that between 81 and 91 percent of certain high-risk diagnosis codes at three audited plans lacked proper supporting records. One major insurer agreed to a settlement worth over one hundred million dollars after government lawyers argued its review programme added diagnoses without checking whether old ones were still valid.
Suddenly, an AI that shows its work is not a nice academic idea. It is the difference between passing an audit and writing a very large cheque. Insurers now need systems where every automated suggestion is tied to evidence a human can inspect. That is exactly the promise of Neuro-Symbolic AI in risk adjustment, where each diagnosis a machine proposes arrives with the clinical proof attached.
The lesson for the rest of us
There is a broader principle here that applies well beyond American health insurance. As AI moves into decisions that carry legal and financial weight, the systems that thrive will not be the cleverest ones. They will be the ones that can be questioned.
Think about how trust works between people. You do not trust a colleague because they are always right. You trust them because when you ask why, they give you an honest answer you can check. Machines are now being held to the same standard, and it is about time.
Regulators across Europe are heading the same way. The EU’s AI Act treats healthcare as high-risk and demands transparency and human oversight for exactly these reasons. Britain’s regulators have signalled similar expectations. The American insurance story is simply an early, expensive preview of a rule that will soon be everywhere: if your algorithm cannot explain itself, it does not belong in decisions about people’s lives.
What to watch next
Over the next few years, expect the phrase “explainable AI” to move from conference slides into contracts. Buyers of AI systems, whether hospitals, insurers, or governments, will start writing evidence trails into their purchasing requirements. Vendors that treated transparency as an optional extra will retrofit it in a hurry.
For patients, this shift is quietly good news. It means the systems reading your medical records are increasingly designed to be checked, challenged, and corrected. The machine still does the heavy lifting. But a human can always look under the bonnet, and the machine has to keep receipts.
The smartest AI in medicine, it turns out, is not the one with the most impressive answers. It is the one that can show its work when someone asks. After a decade of mysterious algorithms, that feels like progress worth noticing.
